Artificial intelligence is transforming the pharmaceutical and life sciences industries at an unprecedented pace. As of January 2024, 80% of professionals in the field are leveraging AI to accelerate drug discovery—cutting timelines from 5–6 years to just one year.

Beyond speed, AI is driving incredible efficiencies, with potential cost reductions of up to 70% and generating an economic impact estimated at $60 billion to $110 billion annually for the pharma and medical-product sectors.

The future of healthcare innovation is here. How is your organization leveraging AI to stay ahead? Share your insights or tag a leader shaping this space.